Health activists and scientists in Europe met to develop strategies to build regional public pharmaceutical infrastructure as pandemic lessons seems lost on governments and producers
Lula’s government is fulfilling his promise to health movements by progressing works on the Health Economic-Industrial Complex, with the aim to provide Brazil’s health system with independence from transnational corporations
A growing number of organizations in Europe is demanding a complete overhaul of regional pharma policies in order to protect people’s health over profits
Pandemic Treaty talks face hurdles as equity concerns, corporate dominance, and calls for fair health frameworks remain unaddressed
A recent deal struck between Johnson & Johnson and the Global Drug Facility promises improved access to bedaquiline in a number of low income countries, but fails to address structural problems
The UK-India FTA could have a drastic impact on the cost of drugs as well as the timely entry of generic medicines in India and other developing countries.
A day ahead of World TB Day, the Indian Patent Office rejected pharma giant Jannsen’s application for a patent extension on drug bedaquiline. If the patent had been extended, public and family budgets would have remained burdened by unjustifiably high costs of the drug
In the heart of Indian capital city New Delhi, dozens of HIV positive patients have been participating in a sit-in for a month right outside the offices of the National AIDS Control Organization or NACO.
Medics for the People has been providing primary health care to people in Belgium for more than 50 years. They recently launched a new mission statement outlining their main streams of work for the upcoming period